Rolando Rodriguez
Cardiovascular Disease · Fort Myers, FLNPI 1114989142
Payments from drug & device makers
Across 63 payments — averaging $33.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$1K
- Johnson & Johnson$278
- E.r. Squibb & Sons, L.L.C.$136
- Abbott$125
- Actelion Pharmaceuticals US, Inc.$98
- Amgen$65
- plus $422 from 17 others
What the payments were for
- Food & beverage$2,129100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 15 | $1,006 |
| Johnson & Johnson | 15 | $278 |
| E.r. Squibb & Sons, L.L.C. | 2 | $136 |
| Abbott | 5 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $98 |
| Amgen | 3 | $65 |
| AstraZeneca | 4 | $62 |
| Amarin Pharma, Inc. | 2 | $41 |
| Biom'up France SAS | 1 | $39 |
| Cardiva Medical, Inc. | 1 | $31 |
| Pfizer | 2 | $25 |
| Lifescan, Inc. | 1 | $23 |
| Boston Scientific | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| Novartis | 1 | $22 |
| Corcept Therapeutics | 1 | $22 |
| Medtronic | 1 | $20 |
| Avvisto Therapeutics, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $12 |
| Preventice Services, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$855
- CAMZYOS$119
How this compares
$2,129 in reported general payments places this provider in the 40th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $54,391 |
| XareltoRivaroxaban | 42 | $49,367 |
| JardianceEmpagliflozin | 37 | $41,085 |
| EntrestoSacubitril/Valsartan | 15 | $14,988 |
| Repatha SureclickEvolocumab | 13 | $10,452 |
| Metoprolol Succinate | 91 | $1,136 |
| Atorvastatin Calcium | 76 | $564 |
| Carvedilol | 33 | $389 |
| Ezetimibe | 20 | $370 |
| Lisinopril | 37 | $368 |
| Amlodipine Besylate | 56 | $314 |
| Metoprolol Tartrate | 40 | $257 |
| Rosuvastatin Calcium | 21 | $217 |
| Losartan Potassium | 22 | $188 |
| ClopidogrelClopidogrel Bisulfate | 18 | $166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $25 | $54,39157 claims |
| Johnson & JohnsonXarelto | $278 | $49,36742 claims |
| Boehringer IngelheimJardiance | $17 | $41,08537 claims |
| NovartisEntresto | $22 | $14,98815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Fort Myers
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.